Intranasal inoculation of recombinant DNA vaccine ABA392 against haemorrhagic septicaemia disease
We evaluate the efficacy of recombinant DNA vaccine ABA392 against haemorrhagic septicaemia infection through intranasal administration route by targeting the mucosal immunity. The DNA vaccine was constructed and subjected to animal study using the Sprague Dawley (SD) rat. The study was divided into...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
John Wiley & Sons
2019
|
| Subjects: |